Mesoblast Statistics

Total Valuation

Mesoblast has a market cap or net worth of AUD 2.57 billion. The enterprise value is 2.71 billion.

Market Cap	2.57B
Enterprise Value	2.71B

Important Dates

The next estimated earnings date is Friday, May 23, 2025.

Earnings Date	May 23, 2025
Ex-Dividend Date	n/a

Share Statistics

Mesoblast has 1.27 billion shares outstanding. The number of shares has increased by 31.98% in one year.

Current Share Class	n/a
Shares Outstanding	1.27B
Shares Change (YoY)	+31.98%
Shares Change (QoQ)	+1.81%
Owned by Insiders (%)	42.12%
Owned by Institutions (%)	21.62%
Float	719.13M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	247.00
PB Ratio	3.12
P/TBV Ratio	n/a
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	-16.21
EV / Sales	295.53
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-39.22

Financial Position

The company has a current ratio of 0.96, with a Debt / Equity ratio of 0.27.

Current Ratio	0.96
Quick Ratio	0.56
Debt / Equity	0.27
Debt / EBITDA	n/a
Debt / FCF	-2.95
Interest Coverage	-2.43

Financial Efficiency

Return on equity (ROE) is -21.31% and return on invested capital (ROIC) is -5.27%.

Return on Equity (ROE)	-21.31%
Return on Assets (ROA)	-4.85%
Return on Invested Capital (ROIC)	-5.27%
Return on Capital Employed (ROCE)	-8.85%
Revenue Per Employee	125,509
Profits Per Employee	-2.29M
Employee Count	73
Asset Turnover	0.01
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +308.08% in the last 52 weeks. The beta is 2.13, so Mesoblast's price volatility has been higher than the market average.

Beta (5Y)	2.13
52-Week Price Change	+308.08%
50-Day Moving Average	2.58
200-Day Moving Average	1.72
Relative Strength Index (RSI)	33.91
Average Volume (20 Days)	9,527,985

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Mesoblast had revenue of AUD 9.16 million and -167.00 million in losses. Loss per share was -0.15.

Revenue	9.16M
Gross Profit	-33.92M
Operating Income	-83.01M
Pretax Income	-166.81M
Net Income	-167.00M
EBITDA	-79.87M
EBIT	-83.01M
Loss Per Share	-0.15

Full Income Statement

Balance Sheet

The company has 61.45 million in cash and 203.78 million in debt, giving a net cash position of -142.33 million or -0.11 per share.

Cash & Cash Equivalents	61.45M
Total Debt	203.78M
Net Cash	-142.33M
Net Cash Per Share	-0.11
Equity (Book Value)	745.35M
Book Value Per Share	0.65
Working Capital	-4.96M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -68.74 million and capital expenditures -295,710, giving a free cash flow of -69.04 million.

Operating Cash Flow	-68.74M
Capital Expenditures	-295,710
Free Cash Flow	-69.04M
FCF Per Share	-0.05

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	-906.03%
Pretax Margin	-1,820.60%
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

Mesoblast does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-31.98%
Shareholder Yield	-31.98%
Earnings Yield	-6.51%
FCF Yield	-2.69%

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Mesoblast has an Altman Z-Score of 0.04. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	0.04
Piotroski F-Score	n/a